About Alxerion Biotech

About company

Alxerion Biotech is a developer of disruptive exosome technologies designed for the discovery and development of new delivery systems for the treatment of cancer and other relevant disorders. The company's technology has created six different families of conventional HTS technologies for cancer, Alzheimer's Disease, cardiovascular disorders, antibiotics, enzyme-activity and oxidation, enabling clinicians to get drugs rare hemophilia and von Willebrand bleeding disorders.